European Medicines Agency approves AstraZeneca jab amid row over supplies

The vice chair of EMA’s human medicines committee, Bruno Sepodes, says the Oxford/AstraZeneca has been authorised for use across the EU. It came amid a deepening row between the EU and AstraZeneca over vaccine supply shortages in the bloc – with Brussels announcing an export ban on some jabs.